BioWorld MedTech

Dec. 31, 2013

FDA clears Electromed's next generation SmartVest system

Electromed (New Prague, Minnesota) has received notification from the FDA that its next generation SmartVest Airway Clearance System, the model SQL, has been cleared to market. Read More

International report: EndoChoice receives clearance of Fuse endoscopy system in Israel

Washington Roundup: Bad payments under Part B trended back up in FY 2013

Court Report: Abbott to pay $5.5 million in physician kickback settlement

OsteoAMP study shows superior fusion results versus rhBMP-2

Health Information technology: Hilo Medical Center achieves acute care Stage 7 award

People in Places

Briefly Noted

MDD's Cardiology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 22, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Sangamo presents primate data for prion suppressor ST-506

BioWorld Science

Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...

TREM2 agonists detailed in Pfizer patent

BioWorld Science

Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.

Roche reports new TREM2 agonists

BioWorld Science

F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...